- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 13.11. | Glucotrack GAAP EPS of -$4.64 | 1 | Seeking Alpha | ||
| 13.11. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11. | Glucotrack, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | Glucotrack sagt außerordentliche Hauptversammlung mangels Quorum ab | 2 | Investing.com Deutsch | ||
| 06.11. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.10. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 08.10. | Glucotrack, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 29.09. | GlucoTrack files to sell 20.06M shares of common stock by selling shareholders | 1 | Seeking Alpha | ||
| 29.09. | Glucotrack, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| 15.09. | GlucoTrack stock tumbles after issuing $3.6M convertible note | 2 | Investing.com | ||
| 11.09. | Glucotrack, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 11.09. | Glucotrack, Inc.: Glucotrack to Participate in the Q3 Virtual Investor Summit | 3 | GlobeNewswire (USA) | ||
| 05.09. | Glucotrack, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 15.08. | Glucotrack GAAP EPS of -$9.62 | 1 | Seeking Alpha | ||
| 14.08. | Glucotrack to submit long-term CGM implant for FDA IDE this year | 1 | MassDevice | ||
| 14.08. | Glucotrack, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 14.08. | GlucoTrack, Inc.: Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | 286 | GlobeNewswire (Europe) | On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device... ► Artikel lesen | |
| 06.08. | Cardiac electrophysiologist Hirsh joins Glucotrack's clinical team | 1 | Investing.com | ||
| 06.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 06.08. | Glucotrack, Inc.: Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology | 189 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people... ► Artikel lesen |
1 2 3 Weiter >>
43 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,160 | -0,12 % | Eckert&Ziegler-Aktie entwickelt sich zum heimlichen Zocker-Liebling - ungewöhnliche Aktivitäten sorgen für maximale Unruhe - clevere Anleger positionieren sich, bevor der Rest aufwacht. | ||
| SERNOVA BIOTHERAPEUTICS | 0,100 | +5,29 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,029 | +6,67 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc. - 8-K, Current Report | ||
| UNIDOC HEALTH | 0,120 | -0,50 % | UniDoc erhält Bestellung für Health Cubes | - Die drei Einheiten sind für Demonstrationszwecke bei Verizon Innovation Labs
bestimmt
VANCOUVER, BC / 25. November 2025 / IRW-Press / UniDoc Health Corp. (CSE: UDOC) (FWB: L7T)... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,322 | 0,00 % | Maxim Group initiates coverage on Co-Diagnostics stock with Buy rating | ||
| EMPOWER CLINICS | - | - | Empower Clinics Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| QUIDELORTHO | 23,600 | 0,00 % | QuidelOrtho Corporation: QuidelOrtho Reports Third Quarter 2025 Financial Results | ? Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ? ... ► Artikel lesen | |
| VERU | 2,445 | +0,20 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 163,75 | +0,40 % | Oracle: Board Expanded With Appointment Of Former Quest Diagnostics Chief Stephen Rusckowski | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics schließt Direktplatzierung über 4,25 Millionen US-Dollar ab | ||
| SENSEONICS | 5,090 | -4,50 % | XFRA 6L60: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| RADNET | 71,50 | 0,00 % | RadNet, Inc.: GE HealthCare and RadNet's DeepHealth Division Sign Letter of Intent to Advance Innovation and Adoption of AI-Powered Imaging Across Multiple Modalities and Remote Scanning | Collaboration aims to expand existing U.S. relationship combining GE HealthCare's mammography systems with DeepHealth's Breast Suite to include a worldwide distribution arrangementIntends to integrate... ► Artikel lesen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +3,38 % bei einem Aktienkurs von 6,720 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.